enGene Therapeutics (ENGNW) Q2 2025 Earnings

12JunConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.51
-0.45
-0.38
-0.32

Details

Expected EPS
-0.497267
Actual EPS
-0.51
Surprise EPS
-0.01
Surprise Percent
+2.56%

Description

enGene Therapeutics (ENGNW) has reported earnings of -0.51 per share for Q2 2025.

0 Comments

Share your thoughts